Skip to content

Perminova Respiratory Effort Accuracy Validation 09-12-2013-Rev 2

Perminova Respiratory Effort Accuracy Validation 09-12-2013-Rev 2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02048436
Enrollment
20
Registered
2014-01-29
Start date
2013-09-30
Completion date
2013-09-30
Last updated
2014-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Rate Accuracy Test

Keywords

Respiratory Rate

Brief summary

The purpose of this study is to validate the accuracy of the Perminova N4 Monitoring system Respiration Rate technology.

Detailed description

After IRB Approval, eighteen volunteer test subjects will be entered into an accuracy study that is designed to validate accuracy of the respiratory rate technology of the Perminova N4 Monitoring system (Device Under Test). The subjects will be selected to represent a range of body types including small, average, muscular, and large with a range of BMI's. A range of stable respiratory rates will be elicited from each volunteer test subject. The rates will be approximately 5, 10, 15, 20, 25, 30, 35 and 40 breaths per minute; with some natural variation from these exact numbers. Each subject will be instrumented with an open system mask that allows for measurement of the end tidal carbon dioxide (EtCO2) respiratory rate and tidal volume. The EtCO2 monitor will be used as the Accuracy Reference Device (Reference) in this study. Performance of the currently released ECG Impedance Respiratory Rate monitor (Acceptance Standard) will be used to establish the acceptance criteria in this study by comparing to Reference.

Interventions

None listed

Sponsors

Clinimark, LLC
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* male * female * 18-45 * range of physiques * healthy

Exclusion criteria

* injury to sensor area * skin inflammation * implanted devices such as pacemakers * pregnant

Design outcomes

Primary

MeasureTime frame
Respiratory Rate of test subject as compared to end tidal CO21 week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026